Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (7)

1

Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms

enthalten in: European journal of haematology | 2023

von Skov, V. | Thomassen, M. | Kjaer, L. | +5

2

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

enthalten in: Cancers | 2023

von Hasselbalch, H. | Junker, P. | Skov, V. | +8

3

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms : minimal residual disease and cure?

enthalten in: Seminars in immunopathology | 2019

von Hasselbalch, H. | Holmström, M.

4

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

enthalten in: Seminars in immunopathology | 2018

von Hasselbalch, H. | Holmström, M.

5

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

enthalten in: Seminars in immunopathology | 2018

von Hasselbalch, H. | Holmström, M.

6

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

enthalten in: Springer Seminars in immunopathology | 2018

von Hasselbalch, H. | Holmström, M.

7

Minimal residual disease after long-term interferon-alpha2 treatment : a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera

enthalten in: Leukemia & lymphoma | 2016

von Utke Rank, C. | Weis Bjerrum, O. | Larsen, T. | +4

1
[1]